These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 6482864)
1. Lymphokine: prospect as a cancer agent. Reynolds RD; Khoiasteh A; Papermaster BW; McEntire J; Garcia A; Kapoor A; Kapoor N; Doyle MK; Walter J; Anson NO Mo Med; 1984 Sep; 81(9):604-6. PubMed ID: 6482864 [No Abstract] [Full Text] [Related]
2. [Lymphokines]. Okuno K; Hamaoka T Gan To Kagaku Ryoho; 1982 Dec; 9(12):2053-64. PubMed ID: 6764096 [TBL] [Abstract][Full Text] [Related]
3. Lymphokines post autologous peripheral blood stem cell transplantation in children. Yaniv I Pediatr Hematol Oncol; 2000; 17(1):9-13. PubMed ID: 10689710 [No Abstract] [Full Text] [Related]
4. On lymphokines, cytokines, and breakthroughs. Moertel CG JAMA; 1986 Dec; 256(22):3141. PubMed ID: 3537345 [No Abstract] [Full Text] [Related]
5. Basal cell carcinomas: treatment with intralesional injection of lymphokine fraction. Rodes ND; McEntire JE; Lopez M; Perez-Mesa C; Gay C; Decker M; Kaltenbach ML; Papermaster BW Mo Med; 1981 Dec; 78(12):735-6, 739. PubMed ID: 7339482 [No Abstract] [Full Text] [Related]
6. The potential of lymphokines in the treatment of cancer. Hamblin AS; Wolstencroft RA; Dumonde DC; Hollander FD; Schuurs AH; Backhouse BM; O'Connell D; Paradinas F Dev Biol Stand; 1977 Apr 13-15; 38():335-41. PubMed ID: 608521 [No Abstract] [Full Text] [Related]
7. [Tumorigenesis, tumor biology and therapeutic measures. New findings]. Gillmann H Arzneimittelforschung; 1987 Feb; 37(2A):236-8. PubMed ID: 2436632 [No Abstract] [Full Text] [Related]
8. [Effect of lymphokines on skin cancer]. Nagy-Vezekényi K; Szabolcsi M; Szegedi G; Sipka S; Dezsö B; Szabó G Z Hautkr; 1980 Dec; 55(24):1630-6. PubMed ID: 7222877 [No Abstract] [Full Text] [Related]
9. Effects of lymphokines in tumour-bearing patients: clinical and laboratory studies. Dumonde DC; Pulley MS; Southcott BM; den Hollender FC Prog Clin Biol Res; 1983; 132E():83-93. PubMed ID: 6647491 [No Abstract] [Full Text] [Related]
10. [Care of advanced tumor treated by interleukin-2 and lymphokine-activated killer cells]. Wu Y; Li LC Zhonghua Hu Li Za Zhi; 1994 Nov; 29(11):654-6. PubMed ID: 7614584 [No Abstract] [Full Text] [Related]
11. Lymphokines and Cytokines, from Clone to Clinic, 1993. Combined meeting of the 8th International Lymphokine Workshop and the 4th International Workshop on Cytokines. Osaka, Japan, October 17-21, 1993. Program and Abstracts. Lymphokine Cytokine Res; 1993 Oct; 12(5):313-419. PubMed ID: 7903162 [No Abstract] [Full Text] [Related]
12. Treatment of experimental visceral leishmaniasis with lymphokine encapsulated in liposomes. Reed SG; Barral-Netto M; Inverso JA J Immunol; 1984 Jun; 132(6):3116-9. PubMed ID: 6725947 [TBL] [Abstract][Full Text] [Related]
13. A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134 [TBL] [Abstract][Full Text] [Related]
14. Genetic medicine gets real. Abbott A Nature; 2001 May; 411(6836):410-2. PubMed ID: 11373641 [No Abstract] [Full Text] [Related]
15. In vitro kinetics of functional parameters of macrophage activation with lymphokines and its relation to tumor cell cytostasis. Matsunaga K; Mashiba H Jpn J Exp Med; 1981 Oct; 51(5):287-92. PubMed ID: 7321254 [TBL] [Abstract][Full Text] [Related]
16. Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. Dumonde DC; Pulley MS; Paradinas FJ; Southcott BM; O'Connell D; Robinson MR; den Hollander F; Schuurs AH J Pathol; 1982 Dec; 138(4):289-308. PubMed ID: 7175605 [TBL] [Abstract][Full Text] [Related]
17. Immunoprophylaxis of Salmonella enteritidis infection by lymphokines in Leghorn chicks. Tellez GI; Kogut MH; Hargis BM Avian Dis; 1993; 37(4):1062-70. PubMed ID: 8141734 [TBL] [Abstract][Full Text] [Related]
18. Clinical application of lymphokines and cytokines. Immunobiology; 1986 Sep; 172(3-5):157-458. PubMed ID: 3542808 [No Abstract] [Full Text] [Related]
19. Rationale and therapeutic basis for patients receiving recombinant interleukin-2. Dudjak LA Semin Oncol Nurs; 1993 Aug; 9(3 Suppl 1):3-7. PubMed ID: 8210792 [No Abstract] [Full Text] [Related]
20. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]